SUBSCRIBE
SUBSCRIBE

IPO

Deals
Myovant Moves From Launch To IPO To Phase 3 Trials In Just 6 Months
January 27, 2017
 · 
1 min read
Cambridge Biotech Jounce Bounces on the IPO Scene, Raises $102 Million
Deals
Cambridge Biotech Jounce Bounces on the IPO Scene, Raises $102 Million
January 27, 2017
 · 
2 min read
Deals
Here’s a Biotech IPO You Don’t Want To Miss
January 9, 2017
 · 
1 min read
3 Biotechs That Could be Taken Out This Quarter
Deals
New Jersey’s Braeburn Pharma Files Paperwork for $150 Million IPO
January 3, 2017
 · 
2 min read
Wall Street's Top Biotech Analyst Loves These 2 Life Science Stocks
Deals
Cambridge-Based Jounce Files for $75 Million IPO
December 30, 2016
 · 
2 min read
Deals
Biotech Pros Say The Sector Is Poised For A Comeback In 2017
December 29, 2016
 · 
1 min read
Deals
Armed With IPO Cash, CRISPR Biotechs Grow Gene-Editing Tech
December 14, 2016
 · 
1 min read
Boy Wonder Ramaswamy's Roivant Bets $116 Million on Arbutus
Deals
Meet the 31-Year Old Man Behind This Year’s Biggest Biotech IPO
October 28, 2016
 · 
3 min read
Deals
Ra Pharma’s $92 Million Debut is the Ninth Massachusetts Biotech IPO of 2016
October 27, 2016
 · 
1 min read
Deals
CRISPR’s Surprisingly Low IPO… Why Are Investors Discouraged?
October 21, 2016
 · 
1 min read
Load More
PRESS RELEASES
Press Releases
HanchorBio Prices IPO at NT$120 Ahead of Innovation Board Listing on May 29
May 26, 2026
 · 
3 min read
Press Releases
Ingenia Therapeutics, a Clinical-Stage Biotechnology Company, Has Received Approval for an Initial Public Offering on the Korea Exchange (KRX)
May 22, 2026
 · 
6 min read
Press Releases
InMed Pharmaceuticals Amends Preferred Investment Options
May 19, 2026
 · 
1 min read
Press Releases
Mobia Medical Announces Pricing of Initial Public Offering
May 8, 2026
 · 
2 min read
Press Releases
Odyssey Therapeutics Announces Pricing of Upsized Initial Public Offering
May 8, 2026
 · 
4 min read
Press Releases
Hemab Therapeutics Announces Closing of Upsized Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
May 4, 2026
 · 
2 min read
Press Releases
Avalyn Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
May 4, 2026
 · 
2 min read
Press Releases
Seaport Therapeutics Announces Pricing of Upsized Initial Public Offering
May 1, 2026
 · 
4 min read
Press Releases
Hemab Therapeutics Announces Pricing of Upsized Initial Public Offering
May 1, 2026
 · 
4 min read
Press Releases
Avalyn Announces Pricing of Upsized Initial Public Offering
April 29, 2026
 · 
4 min read
Press Releases
Kailera Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
April 21, 2026
 · 
2 min read
Press Releases
Kailera Therapeutics Announces Pricing of Initial Public Offering
April 17, 2026
 · 
2 min read
Press Releases
Integrant Awarded Nasdaq Ticker “INGT” Ahead of Highly Anticipated IPO
April 16, 2026
 · 
2 min read
Press Releases
Oricell Therapeutics Closes $110 Million Pre-IPO Financing to Accelerate Global Development of Solid Tumor CAR-T Therapies
April 10, 2026
 · 
5 min read
Press Releases
Diagens Biotechnology Raises US$101 Million in Hong Kong IPO; Shares More Than Double on First Day of Trading
March 31, 2026
 · 
3 min read
Press Releases
Theralase(R) Closes $1.1 M Non-Brokered Private Placement
March 10, 2026
 · 
1 min read
Press Releases
MiniMed announces pricing of initial public offering - March 5, 2026
March 5, 2026
 · 
5 min read
Press Releases
Generate Biomedicines, Inc. Announces Pricing of Initial Public Offering
February 27, 2026
 · 
3 min read
Press Releases
MiniMed announces launch of IPO roadshow
February 24, 2026
 · 
6 min read
Press Releases
Agomab Announces Closing of Initial Public Offering
February 10, 2026
 · 
4 min read
Load More